With this new funding program, the German government has set an ambitious goal of support for innovation with a budget of 1.5 billion euroswhich was even doubled during the Covid-19 health crisis.
Companies can now benefit from a annual tax bonus for their R&D expenses capped at 1 million euros!
G.A.C. Group, an international innovation consulting firm since 2002, offers you a replay of our webinar - in French - for life sciences companies (Food, Health, Pharmaceuticals, Biotechnology, Medicine, Veterinary, etc.) with R&D teams based in Germany.
Our local French-speaking innovation financing expert, Eric BOURGUIGNON, will share with you the key elements to know about this deviceR&D bonus tax incentive called "Forschungszulage".
On the agenda for this webinar:
- Mechanism of the German CIR
- Evaluation with the Frascati criteria
- Methodology and support G.A.C. Group
- Things to remember
To access the replay, fill out the form below.
Clinical trials and medical devices: what really qualifies for the CIR
IP Box: the little-known tax advantage for software publishers and platform developers
Managing innovation in line with business: how to secure your projects and your portfolio?
